Modeling multiple correlated end-organ disease trajectories: A tutorial for multistate and joint models with applications in diabetes complications

被引:0
|
作者
Lovblom, Leif Erik [1 ,2 ,7 ]
Briollais, Laurent [2 ,3 ]
Perkins, Bruce A. [2 ,4 ,5 ]
Tomlinson, George [3 ,5 ,6 ]
机构
[1] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada
[2] Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Biostat Div, Toronto, ON, Canada
[4] Sinai Hlth, Leadership Sinai Ctr Diabet, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, UHN Sinai Hlth, Toronto, ON, Canada
[7] Univ Hlth Network, Biostat Dept, 10EB242A 200 Elizabeth St, Toronto, ON M5G 2C4, Canada
基金
加拿大健康研究院;
关键词
diabetes complications; joint model; longitudinal data; multistate model; multivariate longitudinal outcomes; survival analysis; type; 1; diabetes; LONGITUDINAL DATA; COMPETING RISKS; R PACKAGE; INTERVAL; STATE; TRIAL/EPIDEMIOLOGY; INTERVENTIONS; LIKELIHOOD; EVENT; TIMES;
D O I
10.1002/sim.9984
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
State-of-the-art biostatistics methods allow for the simultaneous modeling of several correlated non-fatal disease processes over time, but there is no clear guidance on the optimal analysis in most settings. An example occurs in diabetes, where it is not known with certainty how microvascular complications of the eyes, kidneys, and nerves co-develop over time. In this article, we propose and contrast two general model frameworks for studying complications (sequential state and parallel trajectory frameworks) and review multivariate methods for their analysis, focusing on multistate and joint modeling. We illustrate these methods in a tutorial format using the long-term follow-up from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study public data repository. A formal comparison of prediction error and discrimination is included. Multistate models are particularly advantageous for determining the order and timing of complications, but require discretization of the longitudinal outcomes and possibly a very complex state space process. Intermittent observation of the states must be accounted for, and discretization is a probable disadvantage in this setting. In contrast, joint models can account for variations of continuous biomarkers over time and are particularly designed for modeling complex association structures between the complications and for performing dynamic predictions of an outcome of interest to inform clinical decisions (eg, a late-stage complication). We found that both models have helpful features that can better-inform our understanding of the complex trajectories that complications may take and can therefore help with decision making for patients presenting with diabetes complications.
引用
收藏
页码:1048 / 1082
页数:35
相关论文
empty
未找到相关数据